nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP2C9—brain cancer	0.631	1	CbGaD
Dextropropoxyphene—CYP2D6—Lomustine—brain cancer	0.072	0.272	CbGbCtD
Dextropropoxyphene—CYP2D6—Hydroxyurea—brain cancer	0.0545	0.206	CbGbCtD
Dextropropoxyphene—CYP3A4—Temozolomide—brain cancer	0.0538	0.204	CbGbCtD
Dextropropoxyphene—CYP3A4—Lomustine—brain cancer	0.0458	0.173	CbGbCtD
Dextropropoxyphene—CYP2C8—Etoposide—brain cancer	0.0273	0.103	CbGbCtD
Dextropropoxyphene—CYP3A4—Etoposide—brain cancer	0.0111	0.0418	CbGbCtD
Dextropropoxyphene—Abnormal behaviour—Temozolomide—brain cancer	0.00252	0.0343	CcSEcCtD
Dextropropoxyphene—OPRM1—telencephalic ventricle—brain cancer	0.00246	0.143	CbGeAlD
Dextropropoxyphene—OPRD1—ganglion—brain cancer	0.00225	0.131	CbGeAlD
Dextropropoxyphene—Metabolic acidosis—Etoposide—brain cancer	0.0019	0.0258	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Lomustine—brain cancer	0.00187	0.0255	CcSEcCtD
Dextropropoxyphene—Digestion impaired—Hydroxyurea—brain cancer	0.00179	0.0244	CcSEcCtD
Dextropropoxyphene—Ataxia—Lomustine—brain cancer	0.00167	0.0227	CcSEcCtD
Dextropropoxyphene—OPRM1—ganglion—brain cancer	0.00153	0.0892	CbGeAlD
Dextropropoxyphene—Coma—Procarbazine—brain cancer	0.00142	0.0193	CcSEcCtD
Dextropropoxyphene—Digestion impaired—Temozolomide—brain cancer	0.0014	0.0191	CcSEcCtD
Dextropropoxyphene—Myopathy—Temozolomide—brain cancer	0.00134	0.0182	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Procarbazine—brain cancer	0.00129	0.0175	CcSEcCtD
Dextropropoxyphene—Visual impairment—Lomustine—brain cancer	0.00118	0.0161	CcSEcCtD
Dextropropoxyphene—Liver injury—Temozolomide—brain cancer	0.00111	0.0152	CcSEcCtD
Dextropropoxyphene—Ataxia—Procarbazine—brain cancer	0.00106	0.0144	CcSEcCtD
Dextropropoxyphene—Drug interaction—Carmustine—brain cancer	0.00105	0.0142	CcSEcCtD
Dextropropoxyphene—Coma—Carmustine—brain cancer	0.000886	0.0121	CcSEcCtD
Dextropropoxyphene—OPRD1—telencephalon—brain cancer	0.000868	0.0505	CbGeAlD
Dextropropoxyphene—Drowsiness—Procarbazine—brain cancer	0.000867	0.0118	CcSEcCtD
Dextropropoxyphene—Jaundice—Procarbazine—brain cancer	0.000845	0.0115	CcSEcCtD
Dextropropoxyphene—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.000803	0.0692	CbGpPWpGaD
Dextropropoxyphene—Hallucination—Procarbazine—brain cancer	0.000774	0.0106	CcSEcCtD
Dextropropoxyphene—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000722	0.0622	CbGpPWpGaD
Dextropropoxyphene—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000704	0.00959	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Procarbazine—brain cancer	0.000695	0.00947	CcSEcCtD
Dextropropoxyphene—Drowsiness—Hydroxyurea—brain cancer	0.000671	0.00914	CcSEcCtD
Dextropropoxyphene—OPRM1—brainstem—brain cancer	0.000667	0.0388	CbGeAlD
Dextropropoxyphene—Ataxia—Carmustine—brain cancer	0.000662	0.00902	CcSEcCtD
Dextropropoxyphene—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000657	0.0566	CbGpPWpGaD
Dextropropoxyphene—Liver function test abnormal—Carmustine—brain cancer	0.00065	0.00885	CcSEcCtD
Dextropropoxyphene—Ataxia—Temozolomide—brain cancer	0.00064	0.00871	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000635	0.00865	CcSEcCtD
Dextropropoxyphene—Syncope—Procarbazine—brain cancer	0.000608	0.00828	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Etoposide—brain cancer	0.0006	0.00818	CcSEcCtD
Dextropropoxyphene—Hallucination—Hydroxyurea—brain cancer	0.000599	0.00817	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Procarbazine—brain cancer	0.000595	0.00811	CcSEcCtD
Dextropropoxyphene—OPRM1—telencephalon—brain cancer	0.000592	0.0344	CbGeAlD
Dextropropoxyphene—Convulsion—Procarbazine—brain cancer	0.000587	0.008	CcSEcCtD
Dextropropoxyphene—CYP3A7—endocrine gland—brain cancer	0.000576	0.0335	CbGeAlD
Dextropropoxyphene—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00056	0.0482	CbGpPWpGaD
Dextropropoxyphene—Confusional state—Procarbazine—brain cancer	0.000558	0.0076	CcSEcCtD
Dextropropoxyphene—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.000554	0.0477	CbGpPWpGaD
Dextropropoxyphene—Vomiting—Lomustine—brain cancer	0.000554	0.00755	CcSEcCtD
Dextropropoxyphene—Shock—Procarbazine—brain cancer	0.000544	0.00741	CcSEcCtD
Dextropropoxyphene—OPRD1—head—brain cancer	0.00054	0.0314	CbGeAlD
Dextropropoxyphene—Tachycardia—Procarbazine—brain cancer	0.00054	0.00735	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—CYP2C9—brain cancer	0.000535	0.18	CrCbGaD
Dextropropoxyphene—OPRK1—head—brain cancer	0.000518	0.0301	CbGeAlD
Dextropropoxyphene—Cardiac arrest—Etoposide—brain cancer	0.000518	0.00705	CcSEcCtD
Dextropropoxyphene—Nausea—Lomustine—brain cancer	0.000517	0.00705	CcSEcCtD
Dextropropoxyphene—Hypotension—Procarbazine—brain cancer	0.000517	0.00704	CcSEcCtD
Dextropropoxyphene—Insomnia—Procarbazine—brain cancer	0.0005	0.00681	CcSEcCtD
Dextropropoxyphene—Propafenone—CYP2C9—brain cancer	0.0005	0.169	CrCbGaD
Dextropropoxyphene—Hepatobiliary disease—Temozolomide—brain cancer	0.000496	0.00675	CcSEcCtD
Dextropropoxyphene—OPRD1—central nervous system—brain cancer	0.000493	0.0287	CbGeAlD
Dextropropoxyphene—Somnolence—Procarbazine—brain cancer	0.000492	0.0067	CcSEcCtD
Dextropropoxyphene—Hallucination—Carmustine—brain cancer	0.000484	0.0066	CcSEcCtD
Dextropropoxyphene—OPRK1—central nervous system—brain cancer	0.000473	0.0275	CbGeAlD
Dextropropoxyphene—Constipation—Procarbazine—brain cancer	0.000473	0.00644	CcSEcCtD
Dextropropoxyphene—Visual impairment—Carmustine—brain cancer	0.000469	0.00639	CcSEcCtD
Dextropropoxyphene—Hallucination—Temozolomide—brain cancer	0.000468	0.00638	CcSEcCtD
Dextropropoxyphene—CYP2D6—hindbrain—brain cancer	0.000466	0.0271	CbGeAlD
Dextropropoxyphene—OPRK1—cerebellum—brain cancer	0.000462	0.0269	CbGeAlD
Dextropropoxyphene—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000459	0.0396	CbGpPWpGaD
Dextropropoxyphene—Feeling abnormal—Procarbazine—brain cancer	0.000456	0.00621	CcSEcCtD
Dextropropoxyphene—Eye disorder—Carmustine—brain cancer	0.000455	0.0062	CcSEcCtD
Dextropropoxyphene—Convulsion—Hydroxyurea—brain cancer	0.000454	0.00619	CcSEcCtD
Dextropropoxyphene—Visual impairment—Temozolomide—brain cancer	0.000453	0.00618	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Procarbazine—brain cancer	0.000452	0.00616	CcSEcCtD
Dextropropoxyphene—Discomfort—Hydroxyurea—brain cancer	0.000441	0.00601	CcSEcCtD
Dextropropoxyphene—Eye disorder—Temozolomide—brain cancer	0.00044	0.00599	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Procarbazine—brain cancer	0.000437	0.00596	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Temozolomide—brain cancer	0.000437	0.00595	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Carmustine—brain cancer	0.000435	0.00593	CcSEcCtD
Dextropropoxyphene—OPRM1—midbrain—brain cancer	0.000425	0.0247	CbGeAlD
Dextropropoxyphene—Immune system disorder—Temozolomide—brain cancer	0.000425	0.00579	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Temozolomide—brain cancer	0.000424	0.00578	CcSEcCtD
Dextropropoxyphene—Malnutrition—Carmustine—brain cancer	0.000424	0.00578	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Hydroxyurea—brain cancer	0.00042	0.00572	CcSEcCtD
Dextropropoxyphene—Modafinil—CYP2C9—brain cancer	0.000419	0.141	CrCbGaD
Dextropropoxyphene—OPRM1—spinal cord—brain cancer	0.000415	0.0241	CbGeAlD
Dextropropoxyphene—Acute coronary syndrome—Etoposide—brain cancer	0.000413	0.00563	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Etoposide—brain cancer	0.000411	0.0056	CcSEcCtD
Dextropropoxyphene—Malnutrition—Temozolomide—brain cancer	0.00041	0.00558	CcSEcCtD
Dextropropoxyphene—Jaundice—Etoposide—brain cancer	0.000409	0.00557	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Procarbazine—brain cancer	0.000407	0.00555	CcSEcCtD
Dextropropoxyphene—Vision blurred—Carmustine—brain cancer	0.000399	0.00544	CcSEcCtD
Dextropropoxyphene—Asthenia—Procarbazine—brain cancer	0.000397	0.00541	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Etoposide—brain cancer	0.000397	0.00541	CcSEcCtD
Dextropropoxyphene—OPRD1—brain—brain cancer	0.000392	0.0228	CbGeAlD
Dextropropoxyphene—Agitation—Carmustine—brain cancer	0.00039	0.00531	CcSEcCtD
Dextropropoxyphene—Vision blurred—Temozolomide—brain cancer	0.000386	0.00526	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Hydroxyurea—brain cancer	0.000381	0.0052	CcSEcCtD
Dextropropoxyphene—Somnolence—Hydroxyurea—brain cancer	0.00038	0.00518	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Procarbazine—brain cancer	0.000378	0.00516	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Hydroxyurea—brain cancer	0.000377	0.00513	CcSEcCtD
Dextropropoxyphene—Agitation—Temozolomide—brain cancer	0.000376	0.00513	CcSEcCtD
Dextropropoxyphene—OPRK1—brain—brain cancer	0.000375	0.0218	CbGeAlD
Dextropropoxyphene—OPRM1—endocrine gland—brain cancer	0.000373	0.0217	CbGeAlD
Dextropropoxyphene—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000369	0.00503	CcSEcCtD
Dextropropoxyphene—OPRM1—head—brain cancer	0.000369	0.0214	CbGeAlD
Dextropropoxyphene—Convulsion—Carmustine—brain cancer	0.000367	0.005	CcSEcCtD
Dextropropoxyphene—Constipation—Hydroxyurea—brain cancer	0.000366	0.00499	CcSEcCtD
Dextropropoxyphene—Dizziness—Procarbazine—brain cancer	0.000366	0.00498	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ESR2—brain cancer	0.000361	0.122	CrCbGaD
Dextropropoxyphene—Convulsion—Temozolomide—brain cancer	0.000355	0.00484	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Hydroxyurea—brain cancer	0.000353	0.00481	CcSEcCtD
Dextropropoxyphene—Eye disorder—Etoposide—brain cancer	0.000352	0.00479	CcSEcCtD
Dextropropoxyphene—Vomiting—Procarbazine—brain cancer	0.000352	0.00479	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Etoposide—brain cancer	0.000349	0.00476	CcSEcCtD
Dextropropoxyphene—Confusional state—Carmustine—brain cancer	0.000349	0.00475	CcSEcCtD
Dextropropoxyphene—Rash—Procarbazine—brain cancer	0.000349	0.00475	CcSEcCtD
Dextropropoxyphene—Dermatitis—Procarbazine—brain cancer	0.000348	0.00475	CcSEcCtD
Dextropropoxyphene—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000347	0.0299	CbGpPWpGaD
Dextropropoxyphene—Headache—Procarbazine—brain cancer	0.000346	0.00472	CcSEcCtD
Dextropropoxyphene—Discomfort—Temozolomide—brain cancer	0.000345	0.00469	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Etoposide—brain cancer	0.00034	0.00463	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Etoposide—brain cancer	0.000339	0.00462	CcSEcCtD
Dextropropoxyphene—Tachycardia—Carmustine—brain cancer	0.000338	0.0046	CcSEcCtD
Dextropropoxyphene—Confusional state—Temozolomide—brain cancer	0.000337	0.00459	CcSEcCtD
Dextropropoxyphene—OPRM1—central nervous system—brain cancer	0.000336	0.0196	CbGeAlD
Dextropropoxyphene—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000334	0.0287	CbGpPWpGaD
Dextropropoxyphene—Nausea—Procarbazine—brain cancer	0.000328	0.00448	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Temozolomide—brain cancer	0.000328	0.00447	CcSEcCtD
Dextropropoxyphene—Hypotension—Carmustine—brain cancer	0.000323	0.0044	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Hydroxyurea—brain cancer	0.000315	0.0043	CcSEcCtD
Dextropropoxyphene—Insomnia—Carmustine—brain cancer	0.000313	0.00426	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Carmustine—brain cancer	0.000308	0.0042	CcSEcCtD
Dextropropoxyphene—Somnolence—Carmustine—brain cancer	0.000308	0.00419	CcSEcCtD
Dextropropoxyphene—Asthenia—Hydroxyurea—brain cancer	0.000307	0.00418	CcSEcCtD
Dextropropoxyphene—Insomnia—Temozolomide—brain cancer	0.000302	0.00412	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Carmustine—brain cancer	0.000299	0.00407	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Temozolomide—brain cancer	0.000298	0.00406	CcSEcCtD
Dextropropoxyphene—Somnolence—Temozolomide—brain cancer	0.000297	0.00405	CcSEcCtD
Dextropropoxyphene—Trimipramine—CYP2C9—brain cancer	0.000296	0.0999	CrCbGaD
Dextropropoxyphene—Constipation—Carmustine—brain cancer	0.000296	0.00403	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Temozolomide—brain cancer	0.000294	0.00401	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Hydroxyurea—brain cancer	0.000293	0.00399	CcSEcCtD
Dextropropoxyphene—Diphenhydramine—CYP2C9—brain cancer	0.000291	0.0981	CrCbGaD
Dextropropoxyphene—CYP2C8—pituitary gland—brain cancer	0.00029	0.0169	CbGeAlD
Dextropropoxyphene—Gastrointestinal disorder—Temozolomide—brain cancer	0.000289	0.00393	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Etoposide—brain cancer	0.000288	0.00393	CcSEcCtD
Dextropropoxyphene—Constipation—Temozolomide—brain cancer	0.000286	0.0039	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Carmustine—brain cancer	0.000285	0.00388	CcSEcCtD
Dextropropoxyphene—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000285	0.0245	CbGpPWpGaD
Dextropropoxyphene—Convulsion—Etoposide—brain cancer	0.000284	0.00387	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP2C9—brain cancer	0.000283	0.0955	CrCbGaD
Dextropropoxyphene—Dizziness—Hydroxyurea—brain cancer	0.000283	0.00386	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Carmustine—brain cancer	0.000283	0.00385	CcSEcCtD
Dextropropoxyphene—Methadone—CYP2C9—brain cancer	0.000281	0.0947	CrCbGaD
Dextropropoxyphene—Discomfort—Etoposide—brain cancer	0.000276	0.00376	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Temozolomide—brain cancer	0.000275	0.00375	CcSEcCtD
Dextropropoxyphene—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000274	0.0236	CbGpPWpGaD
Dextropropoxyphene—Abdominal pain—Carmustine—brain cancer	0.000273	0.00373	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Temozolomide—brain cancer	0.000273	0.00372	CcSEcCtD
Dextropropoxyphene—Vomiting—Hydroxyurea—brain cancer	0.000272	0.00371	CcSEcCtD
Dextropropoxyphene—Rash—Hydroxyurea—brain cancer	0.00027	0.00368	CcSEcCtD
Dextropropoxyphene—Confusional state—Etoposide—brain cancer	0.00027	0.00368	CcSEcCtD
Dextropropoxyphene—Dermatitis—Hydroxyurea—brain cancer	0.00027	0.00367	CcSEcCtD
Dextropropoxyphene—Headache—Hydroxyurea—brain cancer	0.000268	0.00365	CcSEcCtD
Dextropropoxyphene—CYP2D6—brainstem—brain cancer	0.000267	0.0155	CbGeAlD
Dextropropoxyphene—OPRM1—brain—brain cancer	0.000267	0.0155	CbGeAlD
Dextropropoxyphene—Abdominal pain—Temozolomide—brain cancer	0.000264	0.0036	CcSEcCtD
Dextropropoxyphene—Tachycardia—Etoposide—brain cancer	0.000261	0.00356	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Carmustine—brain cancer	0.000255	0.00347	CcSEcCtD
Dextropropoxyphene—Nausea—Hydroxyurea—brain cancer	0.000254	0.00346	CcSEcCtD
Dextropropoxyphene—Hypotension—Etoposide—brain cancer	0.00025	0.00341	CcSEcCtD
Dextropropoxyphene—Asthenia—Carmustine—brain cancer	0.000248	0.00338	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Temozolomide—brain cancer	0.000246	0.00336	CcSEcCtD
Dextropropoxyphene—Asthenia—Temozolomide—brain cancer	0.00024	0.00327	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Etoposide—brain cancer	0.000238	0.00325	CcSEcCtD
Dextropropoxyphene—Somnolence—Etoposide—brain cancer	0.000238	0.00324	CcSEcCtD
Dextropropoxyphene—CYP2D6—telencephalon—brain cancer	0.000237	0.0138	CbGeAlD
Dextropropoxyphene—Diarrhoea—Carmustine—brain cancer	0.000237	0.00323	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Etoposide—brain cancer	0.000231	0.00315	CcSEcCtD
Dextropropoxyphene—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00023	0.0198	CbGpPWpGaD
Dextropropoxyphene—Dizziness—Carmustine—brain cancer	0.000229	0.00312	CcSEcCtD
Dextropropoxyphene—Constipation—Etoposide—brain cancer	0.000229	0.00312	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Temozolomide—brain cancer	0.000229	0.00312	CcSEcCtD
Dextropropoxyphene—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000227	0.0195	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—endocrine gland—brain cancer	0.000225	0.0131	CbGeAlD
Dextropropoxyphene—Dizziness—Temozolomide—brain cancer	0.000221	0.00301	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Etoposide—brain cancer	0.00022	0.003	CcSEcCtD
Dextropropoxyphene—Vomiting—Carmustine—brain cancer	0.00022	0.003	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Etoposide—brain cancer	0.000219	0.00298	CcSEcCtD
Dextropropoxyphene—Rash—Carmustine—brain cancer	0.000218	0.00297	CcSEcCtD
Dextropropoxyphene—Dermatitis—Carmustine—brain cancer	0.000218	0.00297	CcSEcCtD
Dextropropoxyphene—Headache—Carmustine—brain cancer	0.000217	0.00295	CcSEcCtD
Dextropropoxyphene—Vomiting—Temozolomide—brain cancer	0.000213	0.0029	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Etoposide—brain cancer	0.000211	0.00288	CcSEcCtD
Dextropropoxyphene—Rash—Temozolomide—brain cancer	0.000211	0.00287	CcSEcCtD
Dextropropoxyphene—Dermatitis—Temozolomide—brain cancer	0.000211	0.00287	CcSEcCtD
Dextropropoxyphene—Headache—Temozolomide—brain cancer	0.000209	0.00285	CcSEcCtD
Dextropropoxyphene—Nausea—Carmustine—brain cancer	0.000205	0.0028	CcSEcCtD
Dextropropoxyphene—CYP2C9—endocrine gland—brain cancer	0.000199	0.0116	CbGeAlD
Dextropropoxyphene—Nausea—Temozolomide—brain cancer	0.000199	0.00271	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Etoposide—brain cancer	0.000197	0.00269	CcSEcCtD
Dextropropoxyphene—Asthenia—Etoposide—brain cancer	0.000192	0.00262	CcSEcCtD
Dextropropoxyphene—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000187	0.0161	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000186	0.016	CbGpPWpGaD
Dextropropoxyphene—Diarrhoea—Etoposide—brain cancer	0.000183	0.00249	CcSEcCtD
Dextropropoxyphene—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000179	0.0154	CbGpPWpGaD
Dextropropoxyphene—Dizziness—Etoposide—brain cancer	0.000177	0.00241	CcSEcCtD
Dextropropoxyphene—Vomiting—Etoposide—brain cancer	0.00017	0.00232	CcSEcCtD
Dextropropoxyphene—Rash—Etoposide—brain cancer	0.000169	0.0023	CcSEcCtD
Dextropropoxyphene—Dermatitis—Etoposide—brain cancer	0.000169	0.0023	CcSEcCtD
Dextropropoxyphene—Headache—Etoposide—brain cancer	0.000168	0.00228	CcSEcCtD
Dextropropoxyphene—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000167	0.0144	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—brain—brain cancer	0.000161	0.00934	CbGeAlD
Dextropropoxyphene—Nausea—Etoposide—brain cancer	0.000159	0.00217	CcSEcCtD
Dextropropoxyphene—CYP3A4—endocrine gland—brain cancer	0.000152	0.00885	CbGeAlD
Dextropropoxyphene—CYP2D6—endocrine gland—brain cancer	0.00015	0.0087	CbGeAlD
Dextropropoxyphene—CYP2D6—head—brain cancer	0.000148	0.00859	CbGeAlD
Dextropropoxyphene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000144	0.0124	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000142	0.0122	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—central nervous system—brain cancer	0.000137	0.00797	CbGeAlD
Dextropropoxyphene—CYP2D6—central nervous system—brain cancer	0.000135	0.00784	CbGeAlD
Dextropropoxyphene—CYP2D6—cerebellum—brain cancer	0.000132	0.00767	CbGeAlD
Dextropropoxyphene—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000128	0.011	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000122	0.0105	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000118	0.0102	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000117	0.0101	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000117	0.01	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—brain—brain cancer	0.000107	0.00623	CbGeAlD
Dextropropoxyphene—CYP3A7—Biological oxidations—CYP2C9—brain cancer	9.91e-05	0.00853	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	9.77e-05	0.00841	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.59e-05	0.00825	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—PTCH2—brain cancer	8.23e-05	0.00708	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—VAV1—brain cancer	8.08e-05	0.00695	CbGpPWpGaD
Dextropropoxyphene—OPRM1—IL4-mediated signaling events—IRS2—brain cancer	7.82e-05	0.00674	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	7.73e-05	0.00666	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	7.63e-05	0.00657	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—OR4C12—brain cancer	7.21e-05	0.00621	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—OR14C36—brain cancer	7.21e-05	0.00621	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—PTCH2—brain cancer	7.21e-05	0.00621	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Irinotecan Pathway—APC—brain cancer	6.57e-05	0.00565	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—OR14C36—brain cancer	6.55e-05	0.00564	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—OR4C12—brain cancer	6.55e-05	0.00564	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—OR14C36—brain cancer	6.33e-05	0.00545	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—OR4C12—brain cancer	6.33e-05	0.00545	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	6.27e-05	0.0054	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Biological oxidations—CYP2C9—brain cancer	6.2e-05	0.00534	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	6.12e-05	0.00527	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—PTCH2—brain cancer	6.1e-05	0.00525	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	5.82e-05	0.00501	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—OR14C36—brain cancer	5.74e-05	0.00495	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—OR4C12—brain cancer	5.74e-05	0.00495	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—OR4C12—brain cancer	5.35e-05	0.0046	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—OR14C36—brain cancer	5.35e-05	0.0046	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—CYP2C9—brain cancer	5.09e-05	0.00438	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	5.02e-05	0.00432	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—OR4C12—brain cancer	4.86e-05	0.00418	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—OR14C36—brain cancer	4.86e-05	0.00418	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—SHH—brain cancer	4.24e-05	0.00365	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—PTCH2—brain cancer	4.22e-05	0.00363	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—SMO—brain cancer	4.02e-05	0.00346	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—PTCH1—brain cancer	4.02e-05	0.00346	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—RELA—brain cancer	4.01e-05	0.00345	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—OR4C12—brain cancer	3.87e-05	0.00333	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—OR14C36—brain cancer	3.87e-05	0.00333	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—SHH—brain cancer	3.72e-05	0.0032	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PTCH2—brain cancer	3.7e-05	0.00319	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—ABR—brain cancer	3.65e-05	0.00314	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—SMO—brain cancer	3.52e-05	0.00303	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—PTCH1—brain cancer	3.52e-05	0.00303	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—OR4C12—brain cancer	3.39e-05	0.00292	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—OR14C36—brain cancer	3.39e-05	0.00292	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.33e-05	0.00287	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—ABR—brain cancer	3.31e-05	0.00285	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—DTX2—brain cancer	3.29e-05	0.00283	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.28e-05	0.00283	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—ABR—brain cancer	3.2e-05	0.00275	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—SHH—brain cancer	3.14e-05	0.0027	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PTCH2—brain cancer	3.13e-05	0.00269	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—PTCH1—brain cancer	2.98e-05	0.00256	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—SMO—brain cancer	2.98e-05	0.00256	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—ABR—brain cancer	2.9e-05	0.0025	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—DTX2—brain cancer	2.89e-05	0.00248	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—OR4C12—brain cancer	2.87e-05	0.00247	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—OR14C36—brain cancer	2.87e-05	0.00247	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—ABR—brain cancer	2.7e-05	0.00233	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PTCH2—brain cancer	2.49e-05	0.00215	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—ABR—brain cancer	2.46e-05	0.00211	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—DTX2—brain cancer	2.44e-05	0.0021	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HES5—brain cancer	2.42e-05	0.00208	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.38e-05	0.00205	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—STRADA—brain cancer	2.34e-05	0.00202	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—TRPC6—brain cancer	2.31e-05	0.00199	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PTCH2—brain cancer	2.19e-05	0.00188	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—SHH—brain cancer	2.17e-05	0.00187	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HES5—brain cancer	2.12e-05	0.00182	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—TRPC6—brain cancer	2.1e-05	0.00181	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—PTCH1—brain cancer	2.06e-05	0.00178	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—SMO—brain cancer	2.06e-05	0.00178	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—STRADA—brain cancer	2.06e-05	0.00177	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—TRPC6—brain cancer	2.03e-05	0.00174	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ABR—brain cancer	1.96e-05	0.00168	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—SHH—brain cancer	1.91e-05	0.00164	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—GLI2—brain cancer	1.89e-05	0.00163	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PTCH2—brain cancer	1.85e-05	0.00159	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—TRPC6—brain cancer	1.84e-05	0.00158	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PTCH1—brain cancer	1.81e-05	0.00156	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—SMO—brain cancer	1.81e-05	0.00156	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HES5—brain cancer	1.79e-05	0.00154	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—GLI1—brain cancer	1.78e-05	0.00153	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.74e-05	0.0015	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—STRADA—brain cancer	1.74e-05	0.0015	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—VAV1—brain cancer	1.73e-05	0.00149	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ABR—brain cancer	1.72e-05	0.00148	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—TRPC6—brain cancer	1.71e-05	0.00147	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CYP2C9—brain cancer	1.69e-05	0.00146	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SUFU—brain cancer	1.68e-05	0.00145	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GLI2—brain cancer	1.66e-05	0.00143	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—GFAP—brain cancer	1.63e-05	0.0014	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—SHH—brain cancer	1.61e-05	0.00139	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—VAV1—brain cancer	1.57e-05	0.00135	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GLI1—brain cancer	1.56e-05	0.00134	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—TRPC6—brain cancer	1.55e-05	0.00134	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HEY1—brain cancer	1.54e-05	0.00133	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—SMO—brain cancer	1.53e-05	0.00132	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PTCH1—brain cancer	1.53e-05	0.00132	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—VAV1—brain cancer	1.52e-05	0.00131	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—DLL1—brain cancer	1.51e-05	0.0013	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SUFU—brain cancer	1.48e-05	0.00127	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ABR—brain cancer	1.45e-05	0.00125	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—BSG—brain cancer	1.44e-05	0.00124	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GFAP—brain cancer	1.43e-05	0.00123	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.42e-05	0.00122	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GLI2—brain cancer	1.4e-05	0.00121	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—VAV1—brain cancer	1.38e-05	0.00119	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HEY1—brain cancer	1.35e-05	0.00116	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—DLL1—brain cancer	1.32e-05	0.00114	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GLI1—brain cancer	1.32e-05	0.00113	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SHH—brain cancer	1.28e-05	0.00111	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—VAV1—brain cancer	1.28e-05	0.0011	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SUFU—brain cancer	1.25e-05	0.00107	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—IDH1—brain cancer	1.24e-05	0.00107	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TRPC6—brain cancer	1.24e-05	0.00107	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SMO—brain cancer	1.22e-05	0.00105	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PTCH1—brain cancer	1.22e-05	0.00105	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GFAP—brain cancer	1.2e-05	0.00104	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—VAV1—brain cancer	1.16e-05	0.001	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HEY1—brain cancer	1.14e-05	0.000983	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SHH—brain cancer	1.13e-05	0.00097	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—DLL1—brain cancer	1.12e-05	0.000964	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—PIK3CG—brain cancer	1.1e-05	0.000946	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TRPC6—brain cancer	1.09e-05	0.000935	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PTCH1—brain cancer	1.07e-05	0.00092	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SMO—brain cancer	1.07e-05	0.00092	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP2C9—brain cancer	1.06e-05	0.000913	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—PIK3CG—brain cancer	9.98e-06	0.000859	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ENO2—brain cancer	9.79e-06	0.000843	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NOTCH2—brain cancer	9.74e-06	0.000838	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—PIK3CG—brain cancer	9.63e-06	0.000829	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SHH—brain cancer	9.52e-06	0.00082	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VAV1—brain cancer	9.28e-06	0.000799	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TRPC6—brain cancer	9.18e-06	0.00079	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SMO—brain cancer	9.03e-06	0.000777	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PTCH1—brain cancer	9.03e-06	0.000777	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—BSG—brain cancer	9.02e-06	0.000777	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PIK3CG—brain cancer	8.75e-06	0.000753	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP2C9—brain cancer	8.71e-06	0.00075	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NOTCH2—brain cancer	8.54e-06	0.000735	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—PIK3CG—brain cancer	8.14e-06	0.000701	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VAV1—brain cancer	8.14e-06	0.000701	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HES1—brain cancer	7.98e-06	0.000687	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—IDH1—brain cancer	7.76e-06	0.000668	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—IL2—brain cancer	7.73e-06	0.000666	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PDGFRA—brain cancer	7.6e-06	0.000654	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—BSG—brain cancer	7.41e-06	0.000638	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PIK3CG—brain cancer	7.39e-06	0.000637	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SPP1—brain cancer	7.38e-06	0.000635	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—BSG—brain cancer	7.34e-06	0.000632	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NOTCH2—brain cancer	7.22e-06	0.000621	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL2—brain cancer	7.02e-06	0.000605	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HES1—brain cancer	7e-06	0.000603	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VAV1—brain cancer	6.88e-06	0.000592	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—IL2—brain cancer	6.78e-06	0.000584	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IRS2—brain cancer	6.67e-06	0.000575	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PDGFRA—brain cancer	6.67e-06	0.000574	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SPP1—brain cancer	6.47e-06	0.000557	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—IDH1—brain cancer	6.37e-06	0.000548	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.32e-06	0.000544	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—IDH1—brain cancer	6.31e-06	0.000544	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL2—brain cancer	6.16e-06	0.00053	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ENO2—brain cancer	6.13e-06	0.000528	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HES1—brain cancer	5.92e-06	0.000509	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CG—brain cancer	5.89e-06	0.000507	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—APC—brain cancer	5.89e-06	0.000507	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IRS2—brain cancer	5.85e-06	0.000504	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—IL2—brain cancer	5.73e-06	0.000493	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP2C9—brain cancer	5.69e-06	0.00049	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PDGFRA—brain cancer	5.63e-06	0.000485	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SPP1—brain cancer	5.47e-06	0.000471	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—EGFR—brain cancer	5.37e-06	0.000462	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL2—brain cancer	5.2e-06	0.000448	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—APC—brain cancer	5.17e-06	0.000445	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CG—brain cancer	5.17e-06	0.000445	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.14e-06	0.000443	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ENO2—brain cancer	5.03e-06	0.000433	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ENO2—brain cancer	4.99e-06	0.00043	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IRS2—brain cancer	4.95e-06	0.000426	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—BSG—brain cancer	4.84e-06	0.000417	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—EGFR—brain cancer	4.71e-06	0.000405	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—RELA—brain cancer	4.61e-06	0.000397	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ERBB2—brain cancer	4.58e-06	0.000394	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CG—brain cancer	4.49e-06	0.000387	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—APC—brain cancer	4.37e-06	0.000376	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CG—brain cancer	4.37e-06	0.000376	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—IDH1—brain cancer	4.16e-06	0.000358	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL2—brain cancer	4.15e-06	0.000357	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCND1—brain cancer	4.04e-06	0.000348	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RELA—brain cancer	4.04e-06	0.000348	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ERBB2—brain cancer	4.01e-06	0.000346	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CTNNB1—brain cancer	4e-06	0.000345	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—EGFR—brain cancer	3.98e-06	0.000343	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL2—brain cancer	3.64e-06	0.000313	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCND1—brain cancer	3.55e-06	0.000305	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VEGFA—brain cancer	3.52e-06	0.000303	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CTNNB1—brain cancer	3.51e-06	0.000302	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—STAT3—brain cancer	3.49e-06	0.0003	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RELA—brain cancer	3.41e-06	0.000294	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ERBB2—brain cancer	3.39e-06	0.000292	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ENO2—brain cancer	3.29e-06	0.000283	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MYC—brain cancer	3.24e-06	0.000279	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EGFR—brain cancer	3.17e-06	0.000273	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VEGFA—brain cancer	3.09e-06	0.000266	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL2—brain cancer	3.07e-06	0.000265	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—STAT3—brain cancer	3.06e-06	0.000263	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCND1—brain cancer	3e-06	0.000258	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CTNNB1—brain cancer	2.97e-06	0.000255	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MYC—brain cancer	2.84e-06	0.000245	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CG—brain cancer	2.81e-06	0.000242	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EGFR—brain cancer	2.78e-06	0.000239	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TP53—brain cancer	2.66e-06	0.000229	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VEGFA—brain cancer	2.61e-06	0.000225	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—STAT3—brain cancer	2.59e-06	0.000223	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MYC—brain cancer	2.4e-06	0.000207	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EGFR—brain cancer	2.35e-06	0.000202	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TP53—brain cancer	2.34e-06	0.000201	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CG—brain cancer	2.31e-06	0.000199	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CG—brain cancer	2.29e-06	0.000197	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TP53—brain cancer	1.97e-06	0.00017	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CG—brain cancer	1.51e-06	0.00013	CbGpPWpGaD
